Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045067
Filing Date
2024-11-13
Accepted
2024-11-13 14:40:40
Documents
53
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 781265
2 ex31-1.htm EX-31.1 12256
3 ex31-2.htm EX-31.2 13590
4 ex32-1.htm EX-32.1 7921
5 ex32-2.htm EX-32.2 7647
  Complete submission text file 0001493152-24-045067.txt   3425994

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ogen-20240930.xsd EX-101.SCH 29369
7 XBRL CALCULATION FILE ogen-20240930_cal.xml EX-101.CAL 37139
8 XBRL DEFINITION FILE ogen-20240930_def.xml EX-101.DEF 94536
9 XBRL LABEL FILE ogen-20240930_lab.xml EX-101.LAB 244952
10 XBRL PRESENTATION FILE ogen-20240930_pre.xml EX-101.PRE 178513
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 361200
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 241453318
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)